Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 16, 2026 (New) | November 16, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | February 16, 2027 (New) | March 16, 2027 (Renewal/Resubmission/Revision) | May 7, 2027 (AIDS)

Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 in any single year; project period up to 3 years.

Summary: Supports pilot research to prepare for larger-scale studies on improving access, quality, effectiveness, affordability, and utilization of drug, tobacco, or alcohol use disorder treatments and related services, including for comorbid conditions.

Key Information: Applications focused on alcohol use alone are not responsive; both clinical trial and non-trial projects are allowed.